Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib versus best available therapy in Japanese patients
jRCT2080223472Phase 3Completed
- Start
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 3 trial of ruxolitinib (2 arms). Started Mar 2017; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080223472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223472.